Non-Hodgkin Lymphoma of the Stomach in a Patient Treated with Natalizumab
{{output}}
A 61-year-old man with relapsing-remitting multiple sclerosis developed extranodal large B-cell lymphoma of the stomach following monthly natalizumab infusions for 6 years. Development of lymphoproliferative disorders increases with chronic use of immunosuppre... ...
